Skip to content
10-K

Annual Report

Oncology Institute, Inc. DFPH TOI TOIIW

0001799191-26-000007

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 5, 2026 98.84M sh
Shares Diluted FY 2025 · Dec 31, 2025 92.39M sh
Shares Diluted FY 2025 · Dec 31, 2024 75.04M sh
Capex FY 2025 · Dec 31, 2025 $3.2M
Capex FY 2025 · Dec 31, 2024 $3.79M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$24.59M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$26.54M
Long Term Debt FY 2025 · Dec 31, 2025 $77.4M
Long Term Debt FY 2025 · Dec 31, 2024 $93.13M
Stockholders Equity FY 2025 · Dec 31, 2025 −$15.72M
Stockholders Equity FY 2025 · Dec 31, 2024 $3.59M
Stockholders Equity FY 2025 · Dec 31, 2023 $57.03M
Current Liabilities FY 2025 · Dec 31, 2025 $70.96M
Current Liabilities FY 2025 · Dec 31, 2024 $52.22M
Total Liabilities FY 2025 · Dec 31, 2025 $180.38M
Total Liabilities FY 2025 · Dec 31, 2024 $169.13M
Current Assets FY 2025 · Dec 31, 2025 $112.75M
Current Assets FY 2025 · Dec 31, 2024 $112.42M
Total Assets FY 2025 · Dec 31, 2025 $164.66M
Total Assets FY 2025 · Dec 31, 2024 $172.72M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.54
Eps Diluted FY 2025 · Dec 31, 2024 −$0.71
Eps Basic FY 2025 · Dec 31, 2025 −$0.54
Eps Basic FY 2025 · Dec 31, 2024 −$0.71
Sga Expense FY 2025 · Dec 31, 2025 $105.57M
Sga Expense FY 2025 · Dec 31, 2024 $107.83M
Net Income FY 2025 · Dec 31, 2025 −$60.61M
Net Income FY 2025 · Dec 31, 2024 −$64.66M
Operating Income FY 2025 · Dec 31, 2025 −$36.08M
Operating Income FY 2025 · Dec 31, 2024 −$60.12M
Revenue FY 2025 · Dec 31, 2025 $502.73M
Revenue FY 2025 · Dec 31, 2024 $393.41M